{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T22:23:13Z","timestamp":1648851793933},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.remn.2016.09.006","type":"journal-article","created":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T23:45:36Z","timestamp":1479167136000},"page":"152-157","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Relationship between primary tumour 18 F-FDG uptake and immunohistochemical and clinical prognostic parameters in breast carcinoma"],"prefix":"10.1016","volume":"36","author":[{"given":"G.K.","family":"Gedik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Sari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remn.2016.09.006_bib0085","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1007\/s00259-012-2211-z","article-title":"Association of primary tumour FDG uptake with clinical, histopathological and molecular charactestics in breast cancer patients scheduled for neoadjuvant chemotherapy","volume":"39","author":"Koolen","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2016.09.006_bib0090","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.breast.2013.05.003","article-title":"Role of FDG PET\/CT in evaluating surgical outcomes of operable breast cancer-Usefulness for malignant grade of triple-negative cancer","volume":"22","author":"Ohara","year":"2013","journal-title":"Breast"},{"key":"10.1016\/j.remn.2016.09.006_bib0095","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/jjco\/hyn019","article-title":"Clinicopathological and prognostic relevance of uptake level using 18F-flurodeoxyglucose positron emission tomography fusion imaging (18F-FDG PET\/CT) in primary breast cancer","volume":"38","author":"Ueda","year":"2008","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.remn.2016.09.006_bib0100","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/bjs.6459","article-title":"Association between 18F-flurodeoxyglucose uptake and prognostic parameters in breast cancer","volume":"96","author":"Gil-Rendo","year":"2009","journal-title":"Br J Surg"},{"key":"10.1016\/j.remn.2016.09.006_bib0105","first-page":"1766","article-title":"Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays","volume":"36","author":"Dehdashti","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2016.09.006_bib0110","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.hemonc.2015.12.001","article-title":"Relevance of progesterone receptor immunohistochemical staining to oncotype DX recurrence score","volume":"9","author":"Chaudhary","year":"2016","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.remn.2016.09.006_bib0115","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.2967\/jnumed.106.037440","article-title":"The effects of estrogen, progesterone and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions","volume":"48","author":"Mavi","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2016.09.006_bib0120","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1097\/MNM.0000000000000330","article-title":"The clinical significance of standardized uptake value in breast cancer measured using 18F-flurodeoxyglucose positron emission tomography\/computed tomography","volume":"36","author":"Kim","year":"2015","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.remn.2016.09.006_bib0125","first-page":"9","article-title":"Glucose metabolism of breast cancer assessed by 18F-FDG PET: Histologic and immunohistochemical tissue analysis","volume":"42","author":"Avril","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2016.09.006_bib0130","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/BF02303557","article-title":"Positron emission tomography and breast masses: comparison with clinical, mammographic and pathological findings","volume":"1","author":"Crowe","year":"1994","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.remn.2016.09.006_bib0135","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00259-002-0880-8","article-title":"FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters","volume":"29","author":"Buck","year":"2002","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.remn.2016.09.006_bib0140","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00259-012-2244-3","article-title":"Semi-quantitative lymph node assessment of 18F-FDG PET\/CT in locally advanced breast cancer: correlation with biological prognostic factors","volume":"40","author":"Garc\u00eda Vicente","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2016.09.006_bib0145","doi-asserted-by":"publisher","first-page":"5454","DOI":"10.1002\/cncr.27579","article-title":"Standardized uptake value by positron emission tomography\/computed tomography as a prognostic variable in metastatic breast cancer","volume":"118","author":"Morris","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.remn.2016.09.006_bib0150","first-page":"1186","article-title":"Breast imaging with fluorine-18-FDG PET: quantitative image analysis","volume":"38","author":"Avril","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remn.2016.09.006_bib0155","first-page":"108","article-title":"Factors effecting standardized uptake value (SUV) of positron emission tomography (PET) imaging wih 18F-FDG","volume":"93","author":"Wiyaporn","year":"2010","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.remn.2016.09.006_bib0160","first-page":"1972","article-title":"Intratumoal distribution of fluorine-18- fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissue studied by microautoradiography","volume":"33","author":"Kubota","year":"1992","journal-title":"J Nucl Med"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X16301743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X16301743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T14:27:00Z","timestamp":1536244020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253654X16301743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S2253654X16301743"],"URL":"https:\/\/doi.org\/10.1016\/j.remn.2016.09.006","relation":{},"ISSN":["2253-654X"],"issn-type":[{"value":"2253-654X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between primary tumour 18F-FDG uptake and immunohistochemical and clinical prognostic parameters in breast carcinoma","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2016.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Espa\u00f1a, S.L.U. y SEMNIM. All rights reserved.","name":"copyright","label":"Copyright"}]}}